Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma

被引：0
|
作者：
Ray, Arghya
Das, Deepika S.
Song, Yan
Chauhan, Dharminder
Anderson, Kenneth C.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1792
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Identification of novel targets in multiple myeloma for "undruggable" RAS/CDK signaling cascade
    Adamia, Sophia
    Chyra, Zuzana
    O'Keefe, Morgan
    Bhatt, Shruti
    Wen, Kenneth
    Fell, Geoffrey G.
    Tai, Yu-Tzu
    Abiatari, Ivane
    Letai, Anthony
    Dorfman, David M.
    Hideshima, Teru
    Anderson, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S87 - S88
  • [32] Identification Cause of Aberrant Splicing and Novel Drug Targets in Patients with Multiple Myeloma
    Adamia, Sophia
    Hideshima, Teru
    Anderson, Kenneth C.
    BLOOD, 2017, 130
  • [33] Pathogenesis of Extramedullary Multiple Myeloma: From Resistance to Identification of Novel Therapeutic Targets
    Jelinek, Tomas
    Zihala, David
    Sevcikova, Tereza
    Kapustova, Veronika
    Sahinbegovic, Hana
    Sithara, Anjana Anilkumar
    Popkova, Tereza
    Plonkova, Hana
    Broskevicova, Lucie
    Vrana, Jan
    Zidlik, Vladimir
    Havel, Martin
    Koristek, Zdenek
    Bago, Juli R.
    Simicek, Michal
    Hajek, Roman
    BLOOD, 2021, 138
  • [34] Identification of an Immunoglobulin M (IgM) Antibody Against Enolase 1 Protein (ENO1) Derived from HEK-293 Cells in Patients with Kidney Failure
    Mir Hadi Jazayeri
    Maryam Sadri
    Ali Mostafaie
    Reza Nedaeinia
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 1251 - 1257
  • [35] Identification of Novel Therapeutic Targets for Metabolic Syndrome by Functional Gene Screening
    Nakagami, H.
    Katsuya, T.
    Takami, Y.
    Rakugi, H.
    Morishita, R.
    Kaneda, Y.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2009, 31 (06) : 486 - 486
  • [36] The identification of allosteric mechanisms allows utilizing conserved enzymes as novel drug targets
    Fuehring, Jana
    Cramer, Johannes
    Baruch, Petra
    Fedorov, Roman
    Gerardy-Schahn, Rita
    GLYCOBIOLOGY, 2016, 26 (12) : 1432 - 1432
  • [37] Identification of an Immunoglobulin M (IgM) Antibody Against Enolase 1 Protein (ENO1) Derived from HEK-293 Cells in Patients with Kidney Failure
    Jazayeri, Mir Hadi
    Sadri, Maryam
    Mostafaie, Ali
    Nedaeinia, Reza
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (03) : 1251 - 1257
  • [38] Identification of Novel Nuclear Targets of Human Thioredoxin 1
    Wu, Changgong
    Jain, Mohit Raja
    Li, Qing
    Oka, Shin-ichi
    Li, Wenge
    Ah-Ng Tony Kong
    Nagarajan, Narayani
    Sadoshima, Junichi
    Simmons, William J.
    Li, Hong
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (12) : 3507 - 3518
  • [39] Vitamin B1 promotes the ubiquitination of ENO1 in hepatocytes through TRIM21 to alleviate obesity-induced metabolic-associated fatty liver disease
    Wang, Zeng
    Tang, Liming
    OBESITY SURGERY, 2024, 34 : 320 - 320
  • [40] Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
    Grassi, Sara
    Mauri, Laura
    Prioni, Simona
    Cabitta, Livia
    Sonnino, Sandro
    Prinetti, Alessandro
    Giussani, Paola
    FRONTIERS IN PHARMACOLOGY, 2019, 10
12345